Results 71 to 80 of about 8,882 (195)
Bullous pemphigoid of Lever against the background of combined somatic pathology
Лечащий Врач, 2021 Clinical observation of a rare bullous autoimmune dermatosis — bullous pemphigoid — in a patient with concomitant polyorganic somatic pathology is given.
E. N. Efanova +3 more
doaj
Study of Clinical Characteristics of Desquamative Gingivitis in 60 Patients in the North of Spain
International Journal of Dental Hygiene, EarlyView.ABSTRACT Objectives The aim of this study is to know the clinical characteristics of desquamative gingivitis (DG) in a Spanish population in order to make an early diagnosis of this sign and, therefore, the underlying systemic disease. Methods A cross‐sectional study was conducted.
Valeria Sanmartín‐Barragáns +7 more
wiley +1 more source
International Journal of Dermatology, Volume 65, Issue 7, Page 1376-1382, July 2026.ABSTRACT Mucous membrane pemphigoid (MMP) following anti‐programmed cell death‐1 (PD‐1) therapy is rare but increasingly reported. Management of high‐ and low‐risk MMP in this setting and the potential oncologic trade‐offs remain poorly defined. We performed a narrative synthesis of all published cases of anti‐PD‐1‐associated MMP, following MEDLINE ...
Serena Dienes +2 more
wiley +1 more source
Linagliptin-Associated Alopecia and Bullous Pemphigoid
European Journal of Case Reports in Internal Medicine, 2019 Bullous pemphigoid is a chronic autoimmune blistering disease. Recently, several reports suggested dipeptidyl peptidase 4 (DPP-4) inhibitors, also known as gliptins, were a potential cause of drug-induced bullous pemphigoid but not of both bullous ...
Ali Someili +2 more
doaj +1 more source
European S2k guidelines on management of autoimmune blistering diseases in children and adolescents
Journal of the European Academy of Dermatology and Venereology, EarlyView.Autoimmune blistering disorders (AIBDs) in children are rare, challenging to diagnose and treat and often require immunosuppressants. Until now, no paediatric care guidelines existed. The EADV Task Force for AIBDs has developed the consensus‐based recommendations, enabling physicians to adopt a uniform, tailored treatment strategy to improve outcomes ...
A. Nanda +31 more
wiley +1 more source
Psoriasis: Targets and Therapy, 2023 Vito Di Lernia, Francesca Peccerillo, Elena Ficarelli Dermatology Unit, Azienda Unità Sanitaria Locale- IRCCS di Reggio Emilia, Reggio Emilia, ItalyCorrespondence: Vito Di Lernia, Dermatology Unit, Arcispedale Santa Maria Nuova, Azienda USL-IRCCS di ...
Di Lernia V, Peccerillo F, Ficarelli E
doaj
Incidence of P200 pemphigoid: A nationwide study
Journal of the European Academy of Dermatology and Venereology, EarlyView.The anti‐LAMB4 cell‐based immunoassay is a new serological technique that is far superior to dermal immunoblotting for detecting autoantibodies directed against the P200 protein. This method allows a re‐evaluation of the incidence of P200 pemphigoid, which appears to be considerably more frequent than epidermolysis bullosa acquisita.
Fabienne Jouen +7 more
wiley +1 more source
Coexistence of psoriasis with bullous pemphigoid
Indian Dermatology Online Journal, 2012 Psoriasis vulgaris and bullous pemphigoid (BP) represent two clinically well-characterized, chronic, inflammatory skin conditions. The concomitant occurrence of these two entities in a patient is rare.
Raghavendra Rao +4 more
doaj +1 more source
PD‐L1‐Inhibitor‐Associated Hidradenitis Suppurativa
Journal of Cutaneous Pathology, EarlyView.
Annie Jin +2 more
wiley +1 more source